The DOI matches its Crossref record; 33 of the 33 references it cites were found in a registry or an index.
Patterns of FGF-23, DMP1, and MEPE expression in patients with chronic kidney disease
Open accessAbstract
Fibroblast growth factor 23 (FGF-23), dentin matrix protein 1 (DMP1), and matrix extracellular phosphoglycoprotein (MEPE) are skeletal proteins involved in the regulation of phosphate homeostasis and bone metabolism. Circulating FGF-23 levels are increased in patients with chronic kidney disease (CKD); however, FGF-23 skeletal expression and its regulation by DMP1 and MEPE have yet to be evaluated. Thus, expression of these three proteins was characterized by immunohistochemistry in 32 pediatric and young adult patients with CKD stages 2–5. When compared to normal controls, bone FGF-23 and DMP1 expression were increased in all stages of CKD; significant differences in bone FGF-23 and DMP1 expression were not detected between pre-dialysis CKD and dialysis patients. Bone MEPE expression in CKD did not differ from controls. FGF-23 was expressed in osteocyte cell bodies located at the trabecular periphery. DMP1 was widely expressed in osteocyte cell bodies and dendrites throughout bone. MEPE was also expressed throughout bone, but only in osteocyte cell bodies. Bone FGF-23 expression correlated directly with plasma levels of the protein (r=0.43, p<0.01) and with bone DMP1 expression (r=0.54, p<0.01) and expression of both proteins were inversely related to osteoid accumulation. Bone MEPE expression was inversely related to bone volume. In conclusion, skeletal FGF-23 and DMP1 expression are increased in CKD and are related to skeletal mineralization. The patterns of expression of FGF-23, MEPE, and DMP1 differ markedly in trabecular bone, suggesting that individual osteocytes may have specialized functions. Increases in bone FGF-23 and DMP1 expression suggest that osteocyte function is altered early in the course of CKD.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Parfitt, A. M., Drezner, M. K., Glorieux, F. H., Kanis, J. A., Malluche, H., Meunier, P. J., Ott, S. M., & Recker, R. R. (1987) · Journal of Bone and Mineral Research · doi:10.1002/jbmr.5650020617 · Cited by 5,016
Bone Histomorphometry : Standardization of Nomenclature, Symbols, and Units
PARFITT, A. M., Drezner, M. K., Glorieux, F. H., Kanis, J. А., Malluche, H. H., Meunier, P. J., Ott, S. M., & Recker, R. R. (1987) · Journal of Bone and Mineral Research · Cited by 3,258
Moe, S., Drüeke, T., Cunningham, J., Goodman, W., Martin, K., Olgaard, K., Ott, S., Sprague, S., Lameire, N., & Eknoyan, G. (2006) · Kidney International · doi:10.1038/sj.ki.5000414 · Cited by 1,993
Autosomal dominant hypophosphataemic rickets is associated with mutations in FGF23
White, K. E., Evans, W. E., O'Riordan, J. L. H., Speer, M. C., Econs, M. J., Lorenz-Depiereux, B., Grabowski, M., Meitinger, T., & Strom, T. M. (2000) · Nature Genetics · doi:10.1038/81664 · Cited by 1,528
Feng, J. Q., Ward, L. M., Liu, S., Lu, Y., Xie, Y., Yuan, B., Yu, X., Rauch, F., Davis, S. I., Zhang, S., et al. (2006) · Nature Genetics · doi:10.1038/ng1905 · Cited by 1,199 · cited 1×
“growth factor 23 (FGF-23), dentin matrix protein 1 (DMP1), and matrix extracellular phosphoglycoprotein (MEPE), may regulate each other through direct or indirect mechanisms (1;2), and circulating levels of FGF-23 are markedly elevated in patients with CKD (3).”
BackgroundLarsson, T., Nisbeth, U. L. F., Ljunggren, Ö., Jüppner, H., & Jonsson, K. B. (2003) · Kidney International · doi:10.1046/j.1523-1755.2003.00328.x · Cited by 689
Self-citationLorenz-Depiereux, B., Bastepe, M., Benet-Pagès, A., Amyere, M., Wagenstaller, J., Müller-Barth, U., Badenhoop, K., Kaiser, S. M., Rittmaster, R. S., Shlossberg, A. H., et al. (2006) · Nature Genetics · doi:10.1038/ng1868 · Cited by 529
Self-citationDetermination of vitamin D status by radioimmunoassay with an 125I-labeled tracer
Hollis, B. W., Kamerud, J. Q., Selvaag, S. R., Lorenz, J. D., & Napoli, J. L. (1993) · Clinical Chemistry · doi:10.1093/clinchem/39.3.529 · Cited by 432
Portale, A. A., Booth, B. E., Halloran, B. P., & Morris, R. C. (1984) · Journal of Clinical Investigation · doi:10.1172/jci111365 · Cited by 353
Gowen, L. C., Petersen, D. N., Mansolf, A. L., Qi, H., Stock, J. L., Tkalcevic, G. T., Simmons, H. A., Crawford, D. T., Chidsey-Frink, K. L., Ke, H. Z., et al. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m203250200 · Cited by 298
Mineralized tissue cells are a principal source of FGF23
Yoshiko, Y., Wang, H., Minamizaki, T., Ijuin, C., Yamamoto, R., Suemune, S., Kozai, K., Tanne, K., Aubin, J. E., & Maeda, N. (2007) · Bone · doi:10.1016/j.bone.2007.01.017 · Cited by 246
Sensitivity of Fibroblast Growth Factor 23 Measurements in Tumor-Induced Osteomalacia
Imel, E. A., Peacock, M., Pitukcheewanont, P., Heller, H. J., Ward, L. M., Shulman, D., Kassem, M., Rackoff, P., Zimering, M., Dalkin, A., et al. (2006) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2005-2105 · Cited by 226
Bone as a source of FGF23: regulation by phosphate?
Mirams, M., Robinson, B. G., Mason, R. S., & Nelson, A. E. (2004) · Bone · doi:10.1016/j.bone.2004.06.014 · Cited by 213
Tartaix, P. H., Doulaverakis, M., George, A., Fisher, L. W., Butler, W. T., Qin, C., Salih, E., Tan, M., Fujimoto, Y., Spevak, L., et al. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m314114200 · Cited by 189
Martin, A., David, V., Laurence, J. S., Schwarz, P. M., Lafer, E. M., Hedge, A.-M., & Rowe, P. S. N. (2008) · Endocrinology · doi:10.1210/en.2007-1205 · Cited by 173
He, G., Gajjeraman, S., Schultz, D. G., Cookson, D., Qin, C., Butler, W. T., Hao, J., & George, A. (2005) · Biochemistry · doi:10.1021/bi051045l · Cited by 162
Wesseling‐Perry, K., Pereira, R. C., Wang, H., Elashoff, R. M., Sahney, S., Gales, B., Jüppner, H., & Salusky, I. B. (2008) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2008-0326 · Cited by 156
Self-citationPathogenic role of Fgf23 in Dmp1 -null mice
Liu, S., Zhou, J., Tang, W., Menard, R., Feng, J. Q., & Quarles, L. D. (2008) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.90201.2008 · Cited by 144
Alpha‐methylacyl‐CoA racemase: a multi‐institutional study of a new prostate cancer marker
Jiang, Z., Wu, C., Woda, B. A., Iczkowski, K. A., Chu, P. G., Tretiakova, M., Young, R. H., Weiss, L. M., Blute, R., Brendler, C. B., et al. (2004) · Histopathology · doi:10.1111/j.1365-2559.2004.01930.x · Cited by 134
Lu, Y., Ye, L., Yu, S., Zhang, S., Xie, Y., McKee, M. D., Li, Y. C., Kong, J., Eick, J. D., Dallas, S. L., et al. (2006) · Developmental Biology · doi:10.1016/j.ydbio.2006.11.001 · Cited by 129
Inhibition of MEPE cleavage by Phex
Guo, R., Rowe, P. S., Liu, S., Simpson, L. G., Xiao, Z.-S., & Quarles, L. D. (2002) · Biochemical and Biophysical Research Communications · doi:10.1016/s0006-291x(02)02125-3 · Cited by 120
Matrix extracellular phosphoglycoprotein (MEPE) is highly expressed in osteocytes in human bone
Yamada, T., Matsukawa, N., Matsumoto, M., Morimoto, S., Ogihara, T., Ochi, T., Yoshikawa, H., Nampei, A., Hashimoto, J., Hayashida, K., et al. (2004) · Journal of Bone and Mineral Metabolism · doi:10.1007/s00774-003-0468-9 · Cited by 116
Turbin, D. A., Leung, S. C. Y., Cheang, M. C. U., Kennecke, H. F., Montgomery, K. D., McKinney, S. E., Treaba, D. O., Boyd, N., Goldstein, L. C., Badve, S., et al. (2007) · Breast Cancer Research and Treatment · doi:10.1007/s10549-007-9736-z · Cited by 110
Expression and prognostic significance of prothymosin-α and ERp57 in human gastric cancer
Leys, C. M., Nomura, S., LaFleur, B., Ferrone, S., Kaminishi, M., Montgomery, E. A., & Goldenring, J. R. (2006) · Surgery · doi:10.1016/j.surg.2006.05.009 · Cited by 97
Liu, S., Rowe, P. S., Vierthaler, L., Zhou, J., & Quarles, L. D. (2007) · Journal of Endocrinology · doi:10.1677/joe.1.07059 · Cited by 92
Expression of FGF23 is correlated with serum phosphate level in isolated fibrous dysplasia
Kobayashi, K., Imanishi, Y., Koshiyama, H., Miyauchi, A., Wakasa, K., Kawata, T., Goto, H., Ohashi, H., Koyano, H. M., Mochizuki, R., et al. (2005) · Life Sciences · doi:10.1016/j.lfs.2005.09.052 · Cited by 85
Molecular analysis of DMP1 mutants causing autosomal recessive hypophosphatemic rickets
Farrow, E., Davis, S. I., Ward, L. M., Summers, L. J., Bubbear, J. S., Keen, R. W., Stamp, T. C. B., Baker, L. R. I., Bonewald, L. F., & White, K. E. (2008) · Bone · doi:10.1016/j.bone.2008.10.040 · Cited by 73
Gokhale, S., Rosen, D. G., Sneige, N., Diaz, L. K., Resetkova, E., Şahin, A. A., Liu, J., & Albarracin, C. T. (2007) · Applied immunohistochemistry & molecular morphology · doi:10.1097/pai.0b013e31802ee998 · Cited by 69
IL-1β, TNF-α, TGF-β, and bFGF expression in bone biopsies before and after parathyroidectomy
Santos, F. R. L., Moysés, R. M. A., Montenegro, F. L. D. M., Jorgetti, V., & Noronha, I. L. (2003) · Kidney International · doi:10.1046/j.1523-1755.2003.00835.x · Cited by 53
Identification of Full-Length Dentin Matrix Protein 1 in Dentin and Bone
Huang, B., Maciejewska, I., Sun, Y., Peng, T., Qin, D., Lu, Y., Bonewald, L. F., Butler, W. T., Feng, J. Q., & Qin, C. (2008) · Calcified Tissue International · doi:10.1007/s00223-008-9140-7 · Cited by 53
Gomes, S. A., dos Reis, L. M., Oliveira, I. B., Noronha, I. D. L., Jorgetti, V., & Heilberg, I. P. (2007) · Journal of Bone and Mineral Metabolism · doi:10.1007/s00774-007-0788-2 · Cited by 36
Amir, L. R., Jovanovic, A., Perdijk, F. B. T., Toyosawa, S., Everts, V. E., & Bronckers, A. L. J. J. (2007) · Journal of Histochemistry & Cytochemistry · doi:10.1369/jhc.6a7162.2007 · Cited by 31
Use of the transgenic approach to determine the role of DMP1 in phosphate regulation.
Lu, Y., Liu, S., Xie, Y., Yu, S., Quarles, L. D., Bonewald, L. F., & Feng, J. Q. (2007) · PubMed · Cited by 8
Cited by
Bonewald, L. F. (2011) · Journal of Bone and Mineral Research · doi:10.1002/jbmr.320 · Cited by 2,287
Robling, A. G., & Bonewald, L. F. (2020) · Annual Review of Physiology · doi:10.1146/annurev-physiol-021119-034332 · Cited by 539
Update on fibroblast growth factor 23 in chronic kidney disease
Wolf, M. (2012) · Kidney International · doi:10.1038/ki.2012.176 · Cited by 391
Classical and Paradoxical Effects of TNF-α on Bone Homeostasis
Osta, B., Benedetti, G., & Miossec, P. (2014) · Frontiers in Immunology · doi:10.3389/fimmu.2014.00048 · Cited by 387
Forging Forward with 10 Burning Questions on FGF23 in Kidney Disease
Wolf, M. (2010) · Journal of the American Society of Nephrology · doi:10.1681/asn.2009121293 · Cited by 308
Metadata
- Authors
- Pereira, R. C., Jűppner, H., Azucena-Serrano, C. E., Yadin, O., Salusky, I. B., & Wesseling-Perry, K.
- Venue
- Bone
- Publisher
- Elsevier BV
- Published
- 2009-12
- Volume
- 45
- Issue
- 6
- Pages
- 1161-1168
- ISSN
- 1873-2763 (ISSN-L)
- 8756-3282
- OpenAlex
- W1982290615
- Cited by
- 272
- References
- 33
- FWCI
- 10.72
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.